SAN FRANCISCO / ACCESSWIRE / June 27, 2024 / Form Bio, the provider of advanced computational life sciences technology and PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate ...

As companies aim to cut costs and reel in spending amid uncertain macroeconomic conditions, Form Bio thinks it is actually the perfect time to launch its platform. The software company was developed ...

CRD initially partnered with Form Bio to improve a DMD therapeutic candidate that was not yet optimized for manufacturing or reduced immunogenicity. Using long-read sequencing, genome integrity ...

Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster. This partnership brings together GENEWIZ's industry-leading ...

Colossal Bio, a biotech trying to resurrect the woolly mammoth, just spun out its first company. The new company, Form Bio, sells manufacturing software to life sciences companies. Insider got the ...

When George Church, PhD, and co-founders established Colossal Biosciences, they envisioned applying their advancements in CRISPR gene editing to the loss of biodiversity, species preservation, and ...

DALLAS--(BUSINESS WIRE)--Form Bio, the breakthrough AI-powered drug discovery platform, announced today its notable achievements and product advancements for the first half of 2023. The company’s ...

Form Bio provides award-winning software and AI solutions for cell and gene therapy leaders. By combining data, technology and expertise, Form's solutions accelerate timelines from discovery to clinic ...

Partnership leverages AI-powered genome design to optimize AAV constructs, accelerate lead candidate selection, and improve drug substance manufacturability for rare and ultra-rare neuromuscular ...